openPR Logo
Press release

Paclitaxel Injection Market to Remain Lucrative During 2013 - 2019

12-21-2017 01:51 PM CET | Health & Medicine

Press release from: Transparency Market Research

Paclitaxel Injection Market to Remain Lucrative During 2013 -

Paclitaxel injection is a viscous anticancer drug, derived from the bark of the Pacific yew tree. Paclitaxel belongs to the group of drugs called antineoplastic. Paclitaxel injection is primarily used to treat various advanced stage cancer of the breast,ovaries, Kaposi sarcoma and non-small cell lung cancer. It is type of cytoskeletal medication that targets tubulin, which are a type of globular proteins. The body cells that have defects in chromosome segregation, mitotic spindle assembly and cell division are treated Paclitaxel. Paclitaxel works by inhibiting the growth of cancer cells and by stabilizing the microtubule polymer. Paclitaxel injection should be administered under the supervision of an oncologists with experience in chemotherapy.

Request Report TOC @ https://www.transparencymarketresearch.com/paclitaxel-injection-market.html

Advantages of Paclitaxel injection such as immediate results, easy availability and better efficacy are some of the factors that are expected to drive the global Paclitaxel injection market. However, adverse effects such as allergy, leucopenia, blood clots, fever, diarrhea and weight loss are few drawbacksthat could hinder the growth of global Paclitaxel injection market. Moreover, stringent regulatory procedure could also act as the hindrance for the global market.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2025

In the geographical perspective, North America is the largest market for Paclitaxel injection owing to the high incidence and prevalence rate of various cancers. The Asian-Pacific and European region arealso expected to be a potential markets for Paclitaxel injection owing to the increased number of cases of advanced stage cancer patients.

The companies involved in development and manufacturing of Paclitaxel injection are AbraxisBioScience Inc., Abbott Laboratories, Bristol-Myers Squibb, Fresenius Kabi Oncology Ltd., Onco Therapies Ltd., Strides Arcolab Ltd., Sagent Pharmaceuticals Inc. and Novasep, amongst others.

Pre Book Full Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=2025<ype=S

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. 

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Paclitaxel Injection Market to Remain Lucrative During 2013 - 2019 here

News-ID: 872055 • Views:

More Releases from Transparency Market Research

Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights for the USD 15.9 Bn Market 2022-2031
Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights f …
The global handheld marijuana vaporizer market has witnessed remarkable growth in recent years, attributed to the increasing acceptance of medicinal marijuana and the demand for convenient and discreet consumption methods. Valued at US$ 5 billion in 2021, the market is projected to surge at a CAGR of 13.4% to reach US$ 15.9 billion by 2031. This article delves into the factors driving this growth, the evolving market landscape, and the
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And Competitors
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And …
The COVID-19 pandemic has precipitated a remarkable surge in the demand for disinfectant products, with a notable emphasis on disinfectant wipes as an essential tool in maintaining hygiene and preventing the spread of pathogens. This research report delves into the multifaceted landscape of the disinfectant wipes market, elucidating key trends, drivers, and innovations shaping the industry. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70359 Key Players and Market Developments Key players
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn

All 5 Releases


More Releases for Paclitaxel

Global Paclitaxel Market Study 2015-2025, by Segment (Natural Paclitaxel, Semi-s …
Paclitaxel is a mitotic inhibitor used in cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".Paclitaxel is a white crystalline powder, odorless and tasteless. It is insoluble in water and soluble in chloroform, acetone and other organic solvents. The global Paclitaxel
Paclitaxel HPLC Global Market Research Report 2025
Paclitaxel HPLC Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-chemical/paclitaxel-hplc-market/81094 The report firstly introduced the Paclitaxel HPLC basics: definitions, classifications, applications and market
Paclitaxel Global Market Research Report 2025
Paclitaxel Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/paclitaxel-market-3/81092 The report firstly introduced the Paclitaxel basics: definitions, classifications, applications and market overview; product
Paclitaxel Injection Market: Competitive Dynamics & Global Outlook 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Paclitaxel Injection market. Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers. Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once
Paclitaxel Injection Market Revenue Growth Predicted by 2026
The increasing prevalence of cancer is the major driving factor for the significant growth of this market. Paclitaxel injection has better efficiency for the treatment of cancer than other medication, besides that this is also easily available in the market which is responsible for the growth of this market. Major players of paclitaxel injection market are focusing on development of more improved paclitaxel injection which will be a remarkable opportunity
Global Paclitaxel Market Research Report 2017: Novasep, Samyang
In this report, the global Paclitaxel market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Paclitaxel in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Fill